Accuray just announced receiving FDA 510(k) clearance for its Radixact image guided radiotherapy system. It’s an upgrade on their popular TomoTherapy system, with the new device sporting a more powerful linear accelerator, megavoltage computed tomography (MVCT) imaging, and helical delivery of the radiation. It’s expected to be released for sale within the next few months.
“The Radixact System builds upon the unique strengths of the TomoTherapy platform. Expanded delivery capabilities enable treatment with image-guided, intensity-modulated radiation therapy (IG-IMRT, an extremely accurate form of radiation therapy) to an expanded range of patients. New database features make the ring gantry-based system even easier to operate and integrate within a radiation oncology department,” said Jennifer Smilowitz, PhD, clinical associate professor at University of Wisconsin School of Medicine and Public Health who worked on the development of the Radixact.
Source: Accuray…